CCL5 and Middle East respiratory syndrome: Previous studies have shown that the concentrations of RANTES in plasma tended to increase during the late course of the disease, which was consistent with our findings in the survival group (42, 43), similar finding was reported in the late stage of survivors with Middle East respiratory syndrome (MERS) that RANTES marked elevation (44).